GDP audits play a pivotal role in ensuring compliance within your operations. Our professional services offer a comprehensive and independent assessment of your current practices, processes, and procedures, evaluating their alignment with relevant regulatory standards. Through a meticulous audit process, we provide a detailed overview and a summary audit report that highlights areas of non-compliance and suggests improvements.
This not only minimises the risk of unfavourable outcomes during MHRA inspections but also serves to safeguard your business from potential financial and reputational repercussions. Our auditing services cover end-to-end processes or specific business areas and can be tailored to mirror regulatory inspections
By choosing our GDP audit services, you gain a partner dedicated to ensuring that your distribution practices align with regulatory expectations. Our thorough assessments provide you with actionable recommendations to enhance compliance, reduce risk, and fortify the overall quality of your pharmaceutical distribution processes.
Furthermore, we offer first-party, second-party, and third-party auditing services on your behalf, meticulously adhering to stringent GDP standards.
First-party audits are conducted internally by your organisation to assess your own compliance with regulations and standards.
Second-party audits involve auditing suppliers or vendors who are directly involved in your supply chain.
Third-party audits are conducted by independent auditors or organisations not directly affiliated with your company.
Each audit delivers a comprehensive report, highlighting strengths and identifying potential areas of concern or non-compliance. This invaluable information empowers you to make informed commercial and quality decisions aligned with GDP compliance standards.
info@eomisconsultancy.co.uk
01933712313
138 Fitzhugh Rise, Wellingborough, Northamptonshire, NN8 6BU
